Palliative Care Clinical Trials

Our team is dedicated to clinical research in the field of palliative care. For more information on any of these trials, or to find out if you're eligible to participate, contact Carolyn Revta, Palliative Care Clinical Research Operations Director, or 858-822-3614.

Ongoing Studies

Alliance A221301

Status: Currently recruiting identifier: NCT02116530
Eligible: Patients receiving highly-emetogenic chemotherapy
Chemotherapy induced nausea and vomiting (CINV) can have an impact on the quality of life of patients with cancer. This is especially true for patients going through treatments with chemotherapy agents with a higher likelihood to cause vomiting (highly-emetogenic), such as those that contain cisplatin or those that include anthracycline and cyclophosphamide. Previous studies with olanzapine suggest that this medication may be effective in preventing acute and delayed onset CINV in patients receiving highly-emetogenic chemotherapy regimens. The goal of this randomized, phase III study is to assess the efficacy of olanzapine vs. placebo in preventing CINV in patients receiving these type of regimens.

Positive Support in Cancer Care: Emphasizing Quality of Life and Legacy

Status: Currently recruiting
Eligible: Cancer patients who are eligible for or are currently receiving hospice or palliative care
This study focuses on the positive outcomes of providing cancer patients with extra support and attention. Patients included in this study will receive extra support from trained clinicians over the course of approximately two weeks. There will be two groups in the study. One group will be focused on support through storytelling and the creation of a life story (legacy) document. The second group will be focused on general support for daily needs or concerns. The primary goal of this study will help researchers understand the impact of different types of psychosocial support and how this process may positively impact people's well-being and quality of life.


Carolyn Revta
Palliative Care Clinical Research Operations Director
Moores Cancer Center
Phone: 858-822-3614